The historical rank and industry rank for Muller & Phipps (India)'s FCF Margin % or its related term are showing as below:
BOM:501477'
s FCF Margin % Range Over the Past 10 Years
Min: -7.16 Med: 3.14 Max: 53.97
Current: 2.11
During the past 13 years, the highest FCF Margin % of Muller & Phipps (India) was 53.97%. The lowest was -7.16%. And the median was 3.14%.
BOM:501477's FCF Margin % is ranked worse than 53% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 3.22
vs BOM:501477: 2.11
Muller & Phipps (India) FCF Margin % Related Terms
Muller & Phipps (India) FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Muller & Phipps (India)'s FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Muller & Phipps (India) FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Muller & Phipps (India)'s FCF Margin % distribution charts can be found below:
* The bar in red indicates where Muller & Phipps (India)'s FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Muller & Phipps (India) (BOM:501477) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Muller & Phipps (India) and its competitors. According to the industry distribution chart, Muller & Phipps (India) ranks #353 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 53%.
Is Muller & Phipps (India)'s FCF Margin % too high?
Muller & Phipps (India)'s current FCF Margin % is 0.00%. Based on the distribution chart, Muller & Phipps (India) ranks #353 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Muller & Phipps (India) has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Muller & Phipps (India)'s FCF Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Muller & Phipps (India) ranks #353 out of 666 companies for FCF Margin %. This places Muller & Phipps (India) in the lower half of its industry. The industry median FCF Margin % is 3.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.22, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Muller & Phipps (India) and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Muller & Phipps (India)'s current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Muller & Phipps (India) stock overvalued right now?
Based on GuruFocus' analysis, Muller & Phipps (India) (BOM:501477) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹279.80, compared to a current price of ₹212.90 — trading 23.9% below its estimated fair value. The current FCF Margin % is 0.00%. Muller & Phipps (India)'s overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Muller & Phipps (India) (BOM:501477), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Muller & Phipps (India) (BOM:501477) Overvalued in 2026?
Based on GuruFocus' analysis, Muller & Phipps (India) stock appears to be undervalued.
The current stock price of ₹212.90 is trading 23.9% below its estimated GF Value™ of ₹279.80.
GuruFocus considers Muller & Phipps (India) to be Modestly Undervalued.
Key valuation signals for BOM:501477:
FCF Margin %: 0.00%
GF Value™: ₹279.80 vs. price of ₹212.90 (23.9% below fair value)
No single metric tells the full story. See the BOM:501477 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Muller & Phipps (India) Ltd is engaged in the marketing of over-the-counter medical preparations and home care products. The operating segments of the company are Cosmetic/toiletry, Medicated preparation, Food Products, and Others, of which a majority of the revenue is derived from the Medical preparation segment. The company's product portfolio includes medicated dental products, ayurvedic skin ointment, and home care products. Its brand names include Cavisan, Cavidine, and Nixoderm.
54GF Score
Get the complete analysis for BOM:501477
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:501477 has been successfully added to your 
